跳至主要内容
临床试验/CTRI/2020/07/026894
CTRI/2020/07/026894招募中未知

Effect of Atorvastatin on vascular endothelial function in Early Systemic Sclerosis: An open label randomized controlled trial.

Intra Mural Research Fund0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with Systemic Sclerosis with a duration of less than 3 years from the first non-Raynauds symptom, classified as per ACR-EULAR 2013 classification criteria
  • 2.Between 18-65 years of age.
  • 3.No use of lipid-lowering medication within last 6 months.

排除标准

  • 1.Pregnancy
  • 2.Renal dysfunction
  • 3.Diabetes mellitus
  • 4.Known cardiovascular disease or a prior history of stroke
  • 5.History of liver disease
  • 6.New or changed dose of calcium channel blockers or angiotensin receptor blocker in the last 4 weeks
  • 7.known allergy or adverse reaction to statins.
  • 9.Overlap syndromes.
  • 10.Patients with digital gangrene despite being on Calcium Channel Blockers and/or Phosphodiesterase inhibitors.

研究者

发起方
Intra Mural Research Fund

相似试验